» Articles » PMID: 33640230

Rural-Urban Residence and Maternal Hepatitis C Infection, U.S.: 2010-2018

Overview
Journal Am J Prev Med
Specialty Public Health
Date 2021 Feb 28
PMID 33640230
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: The prevalence of hepatitis C virus infection among women delivering live births in the U.S. may be higher in rural areas where county-level estimates may be unreliable. The aim of this study is to model county-level maternal hepatitis C virus infection among deliveries in the U.S.

Methods: In 2020, U.S. natality files (2010-2018) with county-level maternal residence information were used from states that had adopted the 2003 revised U.S. birth certificate, which included a field for hepatitis C virus infection present during pregnancy. Hierarchical Bayesian spatial models with spatiotemporal random effects were applied to produce stable annual county-level estimates of maternal hepatitis C virus infection for years when all states had adopted the revised birth certificate (2016-2018). Models included a 6-Level Urban-Rural County Classification Scheme along with the birth year and county-specific covariates to improve posterior predictions.

Results: Among approximately 32 million live births, the overall prevalence of maternal hepatitis C virus infection was 3.5 per 1,000 births (increased from 2.0 in 2010 to 5.0 in 2018). During 2016-2018, posterior predicted median county-level maternal hepatitis C virus infection rates showed that nonurban counties had 3.5-3.8 times higher rates of hepatitis C virus than large central metropolitan counties. The counties in the top 10th percentile for maternal hepatitis C virus rates in 2018 were generally located in Appalachia, in Northern New England, along the northern border in the Upper Midwest, and in New Mexico.

Conclusions: Further implementation of community-level interventions that are effective in reducing maternal hepatitis C virus infection and its subsequent morbidity may help to reduce geographic and rural disparities.

Citing Articles

Insights into the spatial epidemiology of hepatitis C infection: systematic synthesis of area-level determinants and spatiotemporal analyses.

Gizamba J, Finch B, Wang S, Klausner J BMC Public Health. 2025; 25(1):687.

PMID: 39972312 PMC: 11841175. DOI: 10.1186/s12889-025-21668-w.


Hepatitis C infection seroprevalence in pregnant women worldwide: a systematic review and meta-analysis.

Abbasi F, Almukhtar M, Fazlollahpour-Naghibi A, Alizadeh F, Behzad Moghadam K, Tadi M EClinicalMedicine. 2023; 66:102327.

PMID: 38045801 PMC: 10692665. DOI: 10.1016/j.eclinm.2023.102327.


Testing for Hepatitis C During Pregnancy Among Persons With Medicaid and Commercial Insurance: Cohort Study.

Khan M, Thompson W, Osinubi A, Meyer Rd W, Kaufman H, Armstrong P JMIR Public Health Surveill. 2023; 9:e40783.

PMID: 37756048 PMC: 10568399. DOI: 10.2196/40783.


Maternal hepatitis C prevalence and trends by county, US: 2016-2020.

Ahrens K, Rossen L, Burgess A, Palmsten K, Ziller E Paediatr Perinat Epidemiol. 2022; 37(2):134-142.

PMID: 36372984 PMC: 9918643. DOI: 10.1111/ppe.12934.


Association of Individual and Community Factors With Hepatitis C Infections Among Pregnant People and Newborns.

Patrick S, Dupont W, McNeer E, McPheeters M, Cooper W, Aronoff D JAMA Health Forum. 2022; 2(10):e213470.

PMID: 35977167 PMC: 8727040. DOI: 10.1001/jamahealthforum.2021.3470.

References
1.
Smid M, Metz T, Gordon A . Stimulant Use in Pregnancy: An Under-recognized Epidemic Among Pregnant Women. Clin Obstet Gynecol. 2019; 62(1):168-184. PMC: 6438363. DOI: 10.1097/GRF.0000000000000418. View

2.
Havens P, Anderson J . Updated CDC Recommendations for Universal Hepatitis C Virus Screening Among Adults and Pregnant Women: Implications for Clinical Practice. JAMA. 2020; 323(22):2258-2259. DOI: 10.1001/jama.2020.3693. View

3.
Kim H, Yang J, El-Serag H, Kanwal F . Awareness of chronic viral hepatitis in the United States: An update from the National Health and Nutrition Examination Survey. J Viral Hepat. 2019; 26(5):596-602. DOI: 10.1111/jvh.13060. View

4.
Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G . Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017. MMWR Morb Mortal Wkly Rep. 2019; 67(5152):1419-1427. PMC: 6334822. DOI: 10.15585/mmwr.mm675152e1. View

5.
Koneru A, Nelson N, Hariri S, Canary L, Sanders K, Maxwell J . Increased Hepatitis C Virus (HCV) Detection in Women of Childbearing Age and Potential Risk for Vertical Transmission - United States and Kentucky, 2011-2014. MMWR Morb Mortal Wkly Rep. 2016; 65(28):705-10. DOI: 10.15585/mmwr.mm6528a2. View